Fox Hill Wealth Management acquired a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 11,682 shares of the conglomerate's stock, valued at approximately $2,225,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. EP Wealth Advisors LLC bought a new position in Danaher during the 2nd quarter worth $3,807,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate's stock valued at $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Puzo Michael J acquired a new position in shares of Danaher in the second quarter valued at about $8,624,000. Madison Asset Management LLC bought a new position in Danaher during the second quarter worth about $85,451,000. Finally, Legal & General Group Plc raised its stake in Danaher by 1.0% in the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate's stock worth $1,029,061,000 after purchasing an additional 43,169 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Price Performance
DHR stock opened at $216.41 on Friday. The company's 50-day moving average price is $199.46 and its two-hundred day moving average price is $192.52. The firm has a market cap of $152.13 billion, a P/E ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.77 EPS. On average, analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on DHR shares. Royal Bank Of Canada boosted their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, July 22nd. Wells Fargo & Company dropped their price target on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 22nd. TD Cowen cut their price target on Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Wolfe Research downgraded Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Finally, Stifel Nicolaus dropped their price objective on Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $228.91.
Check Out Our Latest Stock Analysis on Danaher
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
